DISCO Pharmaceuticals is a startup based in Germany, most recent round Seed, 3 tracked investors.
DISCO Pharmaceuticals is a startup based in Germany. Its most recent tracked round is Seed. Brouky records 3 investors associated with the company.
DISCO Pharmaceuticals employs a disruptive proteomics technology to map the surfaceome of cancer cells and develop first-in-class cancer drugs by identifying druggable targets and protein communities on the cancer cell surface.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.